We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KVIKA:OMXICEKvika banki hf Analysis

Data as of 2026-06-26 - not real-time

ISK 13.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kvika banki hf. trades at ISK 13.30, well below its 20‑day SMA of 14.28 and 50‑day SMA of 15.35, indicating a bearish price trend, yet the RSI of 25 suggests the stock is oversold and may be poised for a short‑term bounce. Valuation metrics are attractive – a trailing P/E of 10.73 versus the industry average of 16.86 and a price‑to‑book of 0.86 point to the shares being undervalued. The dividend yield of 2.69% with a modest payout ratio of 29% offers income, but the negative operating cash flow (‑ISK 20.9 bn) raises questions about long‑term cash sustainability. Recent corporate actions – a €150 million senior preferred note issuance at 4.375% and a proposed special dividend of ISK 2.35 per share – provide liquidity and signal confidence from management. Risk factors include high 30‑day volatility (≈48%) and decreasing volume, though beta is exceptionally low (≈0.05), implying limited market‑wide systematic risk. Overall, the stock sits near its technical support of ISK 13.20, with resistance at ISK 16.40, suggesting limited upside in the near term but potential for value‑oriented investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages indicating bearish trend
  • RSI in oversold territory suggests possible rebound
  • Decreasing volume and high volatility increase near‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation multiples relative to peers
  • Attractive dividend yield with low payout ratio
  • Recent capital raise (EUR 150 m notes) improves balance‑sheet flexibility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings growth (≈9% revenue growth) and solid operating margins
  • Low systematic risk (beta ~0.05) despite high idiosyncratic volatility
  • Strategic presence in Iceland and UK offering diversified regional exposure

Key Metrics & Analysis

Financial Health

Revenue Growth9.40%
Profit Margin28.80%
P/E Ratio10.7
ROE8.26%
ROA1.58%
P/B Ratio0.9
Op. Cash FlowISK-20859000832
Industry P/E16.9

Technical Analysis

TrendBearish
RSI25.1
SupportISK 13.20
ResistanceISK 16.40
MA 20ISK 14.28
MA 50ISK 15.35
MA 200ISK 17.31
MACDBearish
VolumeDecreasing
Fear & Greed Index86.13

Valuation

GradeUndervalued
TypeValue
Dividend Yield2.69%

Risk Assessment

Beta0.05
Volatility47.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.